Biokarpet S.A. (ATH:BIOKA)
Greece
· Delayed Price · Currency is EUR 1.790
-0.015 (-0.83%)
Jun 6, 2025, 5:13 PM EET
Biokarpet Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 205.49 | 209.99 | 231.22 | 187.29 | 123.24 | Upgrade
|
| Revenue Growth (YoY) | -2.15% | -9.18% | 23.46% | 51.97% | -2.00% | Upgrade
|
| Cost of Revenue | 174.13 | 174.48 | 189.6 | 155.81 | 99.5 | Upgrade
|
| Gross Profit | 31.37 | 35.51 | 41.63 | 31.48 | 23.74 | Upgrade
|
| Selling, General & Admin | 27.83 | 27.5 | 27.95 | 23.62 | 20.3 | Upgrade
|
| Research & Development | 0.62 | 0.58 | 0.5 | 0.58 | 0.42 | Upgrade
|
| Other Operating Expenses | -2.43 | -0.95 | -0.28 | -0.42 | -0.44 | Upgrade
|
| Operating Expenses | 26.02 | 27.14 | 28.16 | 23.77 | 20.28 | Upgrade
|
| Operating Income | 5.35 | 8.38 | 13.47 | 7.7 | 3.46 | Upgrade
|
| Interest Expense | -6.67 | -6.75 | -3.89 | -3.12 | -2.88 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0.01 | 0.06 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.02 | 0.02 | 0.1 | 0 | 0.07 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.83 | 0.12 | -0.1 | -0.36 | -0.34 | Upgrade
|
| EBT Excluding Unusual Items | -0.51 | 1.77 | 9.57 | 4.23 | 0.38 | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.05 | 0.05 | -0 | -0.03 | -0.15 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.56 | -0.27 | 1.27 | 0.82 | 0.51 | Upgrade
|
| Pretax Income | 1.08 | 6.28 | 10.84 | 5.02 | 0.73 | Upgrade
|
| Income Tax Expense | 0.77 | 0.69 | 1.7 | 0.76 | 0.51 | Upgrade
|
| Earnings From Continuing Operations | 0.31 | 5.58 | 9.13 | 4.26 | 0.22 | Upgrade
|
| Minority Interest in Earnings | -0.01 | -0.09 | -0.14 | -0.06 | -0.02 | Upgrade
|
| Net Income | 0.3 | 5.49 | 8.99 | 4.21 | 0.2 | Upgrade
|
| Net Income to Common | 0.3 | 5.49 | 8.99 | 4.21 | 0.2 | Upgrade
|
| Net Income Growth | -94.49% | -38.94% | 113.87% | 1971.19% | -83.62% | Upgrade
|
| Shares Outstanding (Basic) | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | 24 | 24 | 24 | 24 | 24 | Upgrade
|
| EPS (Basic) | 0.01 | 0.23 | 0.37 | 0.18 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.01 | 0.23 | 0.37 | 0.18 | 0.01 | Upgrade
|
| EPS Growth | -94.49% | -38.94% | 113.87% | 1971.30% | -83.62% | Upgrade
|
| Free Cash Flow | -4.7 | -0.66 | -5.74 | -3.26 | -13.54 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.03 | -0.24 | -0.14 | -0.56 | Upgrade
|
| Gross Margin | 15.26% | 16.91% | 18.00% | 16.81% | 19.27% | Upgrade
|
| Operating Margin | 2.60% | 3.99% | 5.83% | 4.11% | 2.81% | Upgrade
|
| Profit Margin | 0.15% | 2.61% | 3.89% | 2.25% | 0.17% | Upgrade
|
| Free Cash Flow Margin | -2.29% | -0.31% | -2.48% | -1.74% | -10.99% | Upgrade
|
| EBITDA | 10.68 | 13.6 | 17.97 | 12.08 | 7.49 | Upgrade
|
| EBITDA Margin | 5.20% | 6.48% | 7.77% | 6.45% | 6.08% | Upgrade
|
| D&A For EBITDA | 5.33 | 5.22 | 4.5 | 4.37 | 4.02 | Upgrade
|
| EBIT | 5.35 | 8.38 | 13.47 | 7.7 | 3.46 | Upgrade
|
| EBIT Margin | 2.60% | 3.99% | 5.83% | 4.11% | 2.81% | Upgrade
|
| Effective Tax Rate | 71.43% | 11.02% | 15.73% | 15.05% | 70.02% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.